Jammu, India

Srinivas Mahesuni


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Achievements of Srinivas Mahesuni

Introduction

Srinivas Mahesuni, an esteemed inventor based in Jammu, India, has made significant contributions to the field of pharmaceuticals. His work focuses on developing innovative solutions for medical conditions, particularly in the area of male erectile dysfunction.

Latest Patents

Mahesuni holds a noteworthy patent titled "Pyrazolopyrimidinones for the treatment of impotence and process for the preparation thereof." This invention centers around pyrazolopyrimidinone compounds that act as phosphodiesterase type 5 (PDE5) inhibitors. These compounds are characterized by their superior inhibitory activity, showcasing better in vivo efficacy and pharmacokinetic profiles. The designer compounds have demonstrated nanomolar potency, making them vital for treating impotence and male erectile dysfunction.

Career Highlights

Srinivas Mahesuni is associated with the Council of Scientific & Industrial Research, where he conducts valuable research that contributes to the healthcare sector. His dedication to the development of effective pharmaceutical compounds positions him as a key figure in scientific innovation.

Collaborations

Mahesuni works alongside talented colleagues, including Sanghapal Damodhar Sawant and Lakshma Reddy Ginnereddy. Their collaborative efforts enhance the research capabilities within their team, fostering an environment of creativity and progressive research aimed at addressing pressing medical challenges.

Conclusion

Srinivas Mahesuni's work exemplifies the impact that dedicated inventors can have on healthcare through innovative research and development. His patented invention serves as a testament to his commitment to improving the quality of life for those facing medical issues related to erectile dysfunction, marking him as a prominent figure in the realm of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…